Stocks
Editas Medicine (EDIT) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.03 | 1.37 | 1.68 | 0.56 | -0.75 | -2.45 | ||
| Changes by years, y/y, % | -75% | -119% | +23% | -67% | -235% | -51.7% | |||
Editas Medicine. EV/EBITDA
Editas Medicine. EV/EBITDA, changes, %
Editas Medicine (EDIT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 0.40 | -0.13 | -0.95 | -0.75 | -1.88 | -2.45 | |
| Changes by years, y/y, % | -73% | -111% | +279% | -233% | -574% | |||
| Changes by quarters, q/q, % | -30% | -133% | +616% | -20% | +149% | |||
